Transaction #23615 · Form 4 · 0001493152-25-028597
Lipocine Inc. · Stock award · Stock Option (Right to Buy)
Lipocine Inc. · Transacted December 18, 2025 · Filed December 19, 2025
What does this filing report?
An SEC Form 4 filing for Lipocine Inc. records a stock award involving Stock Option (Right to Buy) on December 18, 2025. The reported quantity was 8,629. The filing date is December 19, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Lipocine Inc.
- Company CIK
- 0001535955
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 8,629
- Reported price
- 4.2
- Reference value
- 36,241.8
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 157,668
- Ownership description
- Not reported
- SEC acceptance time
- Dec 19, 2025, 5:09 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Patel Mahesh V. ↗
Chief Executive Officer · Director
CIK 0001579872
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Common Stock
- Underlying quantity
- 8,629
- Conversion / exercise price
- 4.2
- Exercise date
- December 18, 2026
- Expiration date
- December 18, 2035
Filing footnotes & remarks
- F1
- Subject to vesting whereby 1/3 of the shares subject to the award will vest on December 18, 2026, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorate basis over the following two years.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.